Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Urologic Diseases 1 Pancreatic Neoplasms 1 Nephritis 1 Neoplasms 1 Melanoma 1 Mastocytosis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Kidney Diseases 1 Immune System Diseases 1 Hypoxia 1 Glomerulonephritis, IGA 1 Glomerulonephritis 1 Carcinoma, Non-Small-Cell Lung 1 COVID-19 1 Autoimmune Diseases 1

Interventions

Surveys and Questionnaires 3 BNT162 Vaccine 3 Surgical Procedures, Operative 2 sinovac COVID-19 vaccine 1 Serologic Tests 1 Prednisone 1 Molecular Diagnostic Techniques 1 Methylprednisolone 1 Medical Marijuana 1 Magnetic Resonance Spectroscopy 1 Hydroxychloroquine 1 High-Throughput Nucleotide Sequencing 1 Glucocorticoids 1 Drug Therapy 1 Dexamethasone 1 Data Collection 1 CVnCoV COVID-19 vaccine 1 COVID-19 Vaccines 1 COVID-19 Serotherapy 1 Azithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × COVID-19 × Hydroxychloroquine × Clear all

NCT04341207 2020-04-10

ONCOVID

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡